Palantir Technologies has become the leading pick for a contract to overhaul the U.K.’s National Health Service, Bloomberg’s Thomas Seal, Olivia Solon, Alex Wickham, and Kitty Donaldson report. The five-year deal, which may be extended by as long as two years and is worth up to $579M, is designed to the assist the agency with the analysis of medical data, detect patterns, and ultimately revamp its entire system, the authors note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PLTR:
- Privacy Issues Don’t Stop Palantir (NASDAQ:PLTR) Landing New UK Contract
- NVDA, ADBE, MSFT: 3 Companies Aiming to Make AI Safe
- Notable open interest changes for October 2nd
- Unusually active option classes on open September 29th
- Palantir Technologies Stock (NYSE:PLTR): A Cathie Wood Pick for AI Believers